The DOI matches its Crossref record; 310 of the 310 references it cites were found in a registry or an index.
Regulatory T cells in the treatment of disease
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–310 of 310
CaMK4-dependent activation of AKT/mTOR and CREM-α underlies autoimmunity-associated Th17 imbalance
Koga, T., Hedrich, C. M., Mizui, M., Yoshida, N., Otomo, K., Lieberman, L. A., Rauen, T., Crispín, J. C., & Tsokos, G. C. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73411 · Cited by 223
Self-citationRegulatory T‐cell homeostasis: steady‐state maintenance and modulation during inflammation
Smigiel, K. S., Srivastava, S., Stolley, J. M., & Campbell, D. J. (2014) · Immunological Reviews · doi:10.1111/imr.12170 · Cited by 222
Cutting Edge: Increased IL-17–Secreting T Cells in Children with New-Onset Type 1 Diabetes
Marwaha, A. K., Crome, S. Q., Panagiotopoulos, C., Berg, K. B., Qin, H., Ouyang, Q., Xu, L., Priatel, J. J., Levings, M. K., & Tan, R. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001860 · Cited by 221
Rationale for anti-GITR cancer immunotherapy
Knee, D. A., Hewes, B., & Brogdon, J. L. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.06.028 · Cited by 221
Zhou, G., & Levitsky, H. I. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2155 · Cited by 213
Wright, G. P., Notley, C. A., Xue, S.-A., Bendle, G. M., Holler, A., Schumacher, T. N., Ehrenstein, M. R., & Stauss, H. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907396106 · Cited by 213
Genomic definition of multiple ex vivo regulatory T cell subphenotypes
Feuerer, M., Hill, J. A., Kretschmer, K., von Boehmer, H., Mathis, D., & Benoist, C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002006107 · Cited by 213
Adotevi, O., Pere, H., Ravel, P., Haicheur, N., Badoual, C., Merillon, N., Medioni, J., Peyrard, S., Roncelin, S., Verkarre, V., et al. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181f4c208 · Cited by 213
Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity
Paterson, A. M., Lovitch, S. B., Sage, P. T., Juneja, V. R., Lee, Y., Trombley, J. D., Arancibia-Cárcamo, C. V., Sobel, R. A., Rudensky, A. Y., Kuchroo, V. K., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141030 · Cited by 212
A Genome-Wide Association Study of Myasthenia Gravis
Renton, A. E., Pliner, H. A., Provenzano, C., Evoli, A., Ricciardi, R., Nalls, M. A., Marangi, G., Abramzon, Y., Arepalli, S., Chong, S., et al. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2014.4103 · Cited by 206
Kennedy-Nasser, A. A., Ku, S., Castillo-Caro, P., Hazrat, Y., Wu, M.-F., Liu, H., Melenhorst, J., Barrett, A. J., Ito, S., Foster, A., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3205 · Cited by 201
A human anti-IL-2 antibody that potentiates regulatory T cells by a structure-based mechanism
Trotta, E., Bessette, P. H., Silveria, S. L., Ely, L. K., Jude, K. M., Le, D. T., Holst, C. R., Coyle, A., Potempa, M., Lanier, L. L., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0070-2 · Cited by 199
Yu, A., Snowhite, I., Vendrame, F., Rosenzwajg, M., Klatzmann, D., Pugliese, A., & Malek, T. R. (2015) · Diabetes · doi:10.2337/db14-1322 · Cited by 197
Self-citationChowdary Venigalla, R. K., Tretter, T., Krienke, S., Max, R., Eckstein, V., Blank, N., Fiehn, C., Dick Ho, A., & Lorenz, H. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23556 · Cited by 196
Efficient central nervous system remyelination requires T cells
Bieber, A. J., Kerr, S., & Rodriguez, M. (2003) · Annals of Neurology · doi:10.1002/ana.10578 · Cited by 196
Tregs: Where We Are and What Comes Next?
Zhao, H., Liao, X., & Kang, Y. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01578 · Cited by 196
Jiang, S., Herrera, O., & Lechler, R. I. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.07.011 · Cited by 195
Zacchigna, S., Martinelli, V., Moimas, S., Colliva, A., Anzini, M., Nordio, A., Costa, A., Rehman, M., Vodret, S., Pierro, C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04908-z · Cited by 193
Self-citationTorrey, H., Butterworth, J., Mera, T., Okubo, Y., Wang, L., Baum, D., Defusco, A., Plager, S., Warden, S., Huang, D., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aaf8608 · Cited by 182
Warner, L. M., Adams, L. M., & Sehgal, S. N. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370219 · Cited by 180
Lu, L., Xu, X., Zhang, B., Zhang, R., Ji, H., & Wang, X. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-36 · Cited by 177
Nakagawa, H., Sido, J. M., Reyes, E. E., Kiers, V., Cantor, H., & Kim, H.-J. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1604765113 · Cited by 176
Interleukin-2 Activity Can Be Fine Tuned with Engineered Receptor Signaling Clamps
Mitra, S., Ring, A. M., Amarnath, S., Spangler, J. B., Li, P., Ju, W., Fischer, S., Oh, J., Spolski, R., Weiskopf, K., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.04.018 · Cited by 175
Darrasse-Jèze, G., Bergot, A., Durgeau, A., Billiard, F., Salomon, B. L., Cohen, J. L., Bellier, B., Podsypanina, K., & Klatzmann, D. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36628 · Cited by 171
Self-citationDifferential Responses of Human Regulatory T Cells (Treg) and Effector T Cells to Rapamycin
Strauss, L., Czystowska, M., Szajnik, M., Mandapathil, M., & Whiteside, T. L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005994 · Cited by 171
Homogeneous Expansion of Human T-Regulatory Cells Via Tumor Necrosis Factor Receptor 2
Okubo, Y., Mera, T., Wang, L., & Faustman, D. L. (2013) · Scientific Reports · doi:10.1038/srep03153 · Cited by 170
Lesokhin, A. M., Callahan, M. K., Postow, M. A., & Wolchok, J. D. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.3010274 · Cited by 169
Depletion of regulatory T cells by anti-GITR mAb as a novel mechanism for cancer immunotherapy
Coe, D., Begom, S., Addey, C., White, M., Dyson, J., & Chai, J.-G. (2010) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-010-0866-5 · Cited by 168
Kang, H.-K., Michaels, M. A., Berner, B. R., & Datta, S. K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3247 · Cited by 167
Bernasconi, A., Marino, R., Ribas, A., Rossi, J., Ciaccio, M., Oleastro, M., Ornani, A., Paz, R., Rivarola, M. A., Zelazko, M., et al. (2006) · Pediatrics · doi:10.1542/peds.2005-2882 · Cited by 167
Lyssuk, E. Y., Torgashina, A. V., Soloviev, S. K., Nassonov, E. L., & Bykovskaia, S. N. (2007) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-72005-0_12 · Cited by 167
Powell, D. J., Felipe-Silva, A., Merino, M. J., Ahmadzadeh, M., Allen, T., Levy, C., White, D. E., Mavroukakis, S., Kreitman, R. J., Rosenberg, S. A., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.7.4919 · Cited by 166
Kato, H., & Perl, A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301859 · Cited by 165
PTEN inhibits IL-2 receptor-mediated expansion of CD4+CD25+ Tregs
Walsh, P. T. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28057 · Cited by 164
Budhu, S., Schaer, D., Li, Y., Toledo‐Crow, R., Panageas, K. S., Yang, X., Zhong, H., Houghton, A. N., Silverstein, S. C., Merghoub, T., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aak9702 · Cited by 162
Schaer, D. A., Budhu, S., Liu, C., Bryson, C., Malandro, N., Cohen, A., Zhong, H., Yang, X., Houghton, A. N., Merghoub, T., et al. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0086 · Cited by 160
Site-Directed Pegylation of Recombinant Interleukin-2 at its Glycosylation Site
Goodson, R. J., & Katre, N. V. (1990) · Nature Biotechnology · doi:10.1038/nbt0490-343 · Cited by 159
Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion
Chopra, M., Biehl, M., Steinfatt, T., Brandl, A., Kums, J., Amich, J., Vaeth, M., Kuen, J., Holtappels, R., Podlech, J., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151563 · Cited by 159
Hurdles in therapy with regulatory T cells
Trzonkowski, P., Bacchetta, R., Battaglia, M., Berglund, D., Bohnenkamp, H. R., ten Brinke, A., Bushell, A., Cools, N., Geissler, E. K., Gregori, S., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa7721 · Cited by 147
Modulation of GITR for cancer immunotherapy
Schaer, D., Murphy, J. T., & Wolchok, J. D. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.12.011 · Cited by 147
The role of regulatory T cells in cancer immunology
Whiteside, T. L. (2015) · ImmunoTargets and Therapy · doi:10.2147/itt.s55415 · Cited by 145
Desar, I. M. E., Jacobs, J. F. M., Hulsbergen‐vandeKaa, C. A., Oyen, W. J. G., Mulders, P., van der Graaf, W. T. A., Adema, G. J., van Herpen, C. M. L., & de Vries, I. J. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25674 · Cited by 140
Hindley, J. P., Ferreira, C., Jones, E., Lauder, S. N., Ladell, K., Wynn, K. K., Betts, G. J., Singh, Y., Price, D. A., Godkin, A. J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1797 · Cited by 140
Isolation of CD4+CD25+ Regulatory T Cells for Clinical Trials
Hoffmann, P., Boeld, T. J., Eder, R., Albrecht, J., Doser, K., Piseshka, B., Dada, A. M., Niemand, C., Assenmacher, M., Orsó, E., et al. (2006) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2006.01.005 · Cited by 137
Oaks, Z., Winans, T., Caza, T., Fernandez, D., Liu, Y., Landas, S. K., Banki, K., & Perl, A. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39791 · Cited by 136
Gutierrez‐Ramos, J. C., Andreu, J. L., Revilla, Y., Viñuela, E., & Martínez-A, C. (1990) · Nature · doi:10.1038/346271a0 · Cited by 136
RORα-expressing T regulatory cells restrain allergic skin inflammation
Malhotra, N., Leyva-Castillo, J. M., Jadhav, U., Barreiro, O., Kam, C., O’Neill, N. K., Meylan, F., Chambon, P., von Andrian, U. H., Siegel, R. M., et al. (2018) · Science Immunology · doi:10.1126/sciimmunol.aao6923 · Cited by 134
Hahn, B. H., Singh, R. P., Cava, A. L., & Ebling, F. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.11.7728 · Cited by 133
Thiruppathi, M., Rowin, J., Ganesh, B. B., Sheng, J. R., Prabhakar, B. S., & Meriggioli, M. N. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.09.012 · Cited by 133
Nadeau, K. C., Hwa, V., & Rosenfeld, R. G. (2011) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.12.042 · Cited by 129
Improved cancer immunotherapy by a CD25-mimobody conferring selectivity to human interleukin-2
Arenas-Ramirez, N., Zou, C., Popp, S. L., Zingg, D., Brannetti, B., Wirth, E., Calzascia, T., Kovařík, J., Sommer, L., Zenke, G., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aag3187 · Cited by 129
Vargas-Rojas, M., Crispín, J. C., Richaud‐Patín, Y., & Alcocer-Varela, J. C. (2008) · Lupus · doi:10.1177/0961203307088307 · Cited by 128
Cheng, G., Yuan, X., Tsai, M. S., Podack, E. R., Yu, A., & Malek, T. R. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103768 · Cited by 127
Self-citationSadelain, M. (2017) · Cell · doi:10.1016/j.cell.2017.12.002 · Cited by 126
Lee, K., Nguyen, V. Q., Lee, K.-M., Kang, S., & Tang, Q. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12509 · Cited by 125
Regulatory T‐cell heterogeneity and the cancer immune response
Ward‐Hartstonge, K. A., & Kemp, R. A. (2017) · Clinical & Translational Immunology · doi:10.1038/cti.2017.43 · Cited by 122
Bruder, D., Westendorf, A. M., Hansen, W., Prettin, S., Gruber, A. D., Qian, Y., von Boehmer, H., Mahnke, K., & Buer, J. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3395 · Cited by 119
Development of thymic Foxp3+ regulatory T cells: TGF‐β matters
Chen, W., & Konkel, J. E. (2015) · European Journal of Immunology · doi:10.1002/eji.201444999 · Cited by 118
Mizui, M., Koga, T., Lieberman, L. A., Beltrán, J., Yoshida, N., Johnson, M. C., Tisch, R., & Tsokos, G. C. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400977 · Cited by 116
Self-citationModulation of T reg cells/ T effector function by GITR signaling is context–dependent
Ephrem, A., Epstein, A. L., Stephens, G. L., Thornton, A. M., Glass, D. D., & Shevach, E. M. (2013) · European Journal of Immunology · doi:10.1002/eji.201343451 · Cited by 115
Masuda, M., Matsumoto, M., Tanaka, S., Nakajima, K., Yamada, N., 井戸, 信., Ohtsuka, T., Nishida, M., Hirano, T., & Utsumi, H. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.03.016 · Cited by 114
Yeh, P., Landais, D., Lemaitre, M. M., Maury, I., Crenne, J.-Y., Becquart, J., Murry‐Brelier, A., Boucher, F., Montay, G., & Fleer, R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1904 · Cited by 113
IL-2 Family of Cytokines in T Regulatory Cell Development and Homeostasis
Malek, T. R., Yu, A., Zhu, L., Matsutani, T., Adeegbe, D. O., & Bayer, A. L. (2008) · Journal of Clinical Immunology · doi:10.1007/s10875-008-9235-y · Cited by 112
Self-citationKoga, T., Ichinose, K., Mizui, M., Crispín, J. C., & Tsokos, G. C. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201785 · Cited by 109
Self-citationLiao, G., Nayak, S., Regueiro, J. R., Berger, S. B., Detre, C., Ros, X. R., Malefyt, R. D. W., Chatila, T. A., Herzog, R. W., & Terhorst, C. (2010) · International Immunology · doi:10.1093/intimm/dxq001 · Cited by 108
Harnessing Regulatory T Cells for Clinical Use in Transplantation: The End of the Beginning
Juvet, S., Whatcott, A., Bushell, A., & Wood, K. J. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12647 · Cited by 93
Thymocyte apoptosis drives the intrathymic generation of regulatory T cells
Konkel, J. E., Jin, W., Abbatiello, B., Grainger, J. R., & Chen, W. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320319111 · Cited by 92
Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells
Bell, C. J. M., Sun, Y. S., Nowak, U. M., Clark, J., Howlett, S., Pekalski, M. L., Yang, X., Ast, O., Waldhauer, I., Freimoser–Grundschober, A., et al. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.10.002 · Cited by 87
Link, W., Oyarzábal, J., Serelde, B. G., Albarran, M. I., Rabal, O., Cebriá, A., Alfonso, P., Fominaya, J. M., Renner, O., Peregrina, S., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.038984 · Cited by 83
Transcriptional control of regulatory T cell development and function
Luo, C. T., & Li, M. O. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.08.003 · Cited by 82
Tkachev, V., Furlan, S. N., Watkins, B. K., Hunt, D. J., Zheng, H. B., Panoskaltsis‐Mortari, A., Betz, K., Brown, M., Schell, J. B., Zeleski, K., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan3085 · Cited by 82
HDAC inhibitor therapy in autoimmunity and transplantation
Hancock, W. W., Akimova, T., Beier, U. H., Liu, Y., & Wang, L. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200593 · Cited by 78
Taylor, P. A., Ehrhardt, M. J., Lees, C. J., Tolar, J., Weigel, B. J., Panoskaltsis‐Mortari, A., Serody, J. S., Brinkmann, V., & Blazar, B. R. (2007) · Blood · doi:10.1182/blood-2007-05-087940 · Cited by 78
Chang, D.-K., Peterson, E., Sun, J., Goudie, C., Drapkin, R., Liu, J. F., Matulonis, U. A., Zhu, Q. K., & Marasco, W. A. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1090075 · Cited by 77
Abuse of Cimetidine in Outpatient Practice
STILLER, C. R., Laupacis, A., Dupre, J., Jenner, M., Keown, P. A., Rodger, W., & Wolfe, B. M. J. (1983) · New England Journal of Medicine · doi:10.1056/nejm198305193082012 · Cited by 76
Soares, K. C., Rucki, A. A., Kim, V., Foley, K., Solt, S., Wolfgang, C. L., Jaffee, E. M., & Zheng, L. (2015) · Oncotarget · doi:10.18632/oncotarget.5656 · Cited by 74
Emerging roles of regulatory T cells in tumour progression and metastasis
Halvorsen, E. C., Mahmoud, S., & Bennewith, K. L. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-014-9529-x · Cited by 74
Mobilization of natural killer cells inhibits development of collagen-induced arthritis
Leavenworth, J. W., Wang, X., Wenander, C. S., Spee, P., & Cantor, H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112188108 · Cited by 74
Attia, P., Powell, D. J., Maker, A. V., Kreitman, R. J., Pastan, I. H., & Rosenberg, S. A. (2006) · Journal of Immunotherapy · doi:10.1097/01.cji.0000187959.45803.0c · Cited by 73
The inflammatory milieu in the rheumatic joint reduces regulatory T‐cell function
Herrath, J., Müller, M., Amoudruz, P., Janson, P., Michaëlsson, J., Larsson, P. T., Trollmo, C., Raghavan, S., & Malmström, V. (2011) · European Journal of Immunology · doi:10.1002/eji.201041004 · Cited by 72
Ishida, T., Utsunomiya, A., Jo, T., Yamamoto, K., Kato, K., Yoshida, S., Takemoto, S., Suzushima, H., Kobayashi, Y., Imaizumi, Y., et al. (2017) · Cancer Science · doi:10.1111/cas.13343 · Cited by 72
A TNFR2-Agonist Facilitates High Purity Expansion of Human Low Purity Treg Cells
He, X., Landman, S., Bauland, S. C. G., van den Dolder, J., Koenen, H. J. P. M., & Joosten, I. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156311 · Cited by 69
Jee, Y., Piao, W., Liu, R., Bai, X., Rhodes, S., Rodebaugh, R. F., Campagnolo, D. I., Shi, F., & Vollmer, T. L. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.05.020 · Cited by 68
Chen, Y., Efebera, Y. A., Johnston, L., Ball, E. D., Avigan, D., Lekakis, L. J., Bachier, C. R., Martin, P. J., Duramad, O., Ishii, Y., et al. (2017) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2017.01.069 · Cited by 67
Tissue resident regulatory T cells: novel therapeutic targets for human disease
Zhou, X., Tang, J., Cao, H., Fan, H., & Li, B. (2015) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.23 · Cited by 66
Human lung tumor FOXP3+ Tregs upregulate four “Treg-locking” transcription factors
Akimova, T., Zhang, T., Negorev, D. G., Singhal, S. K., Stadanlick, J. E., Rao, A., Annunziata, M. J., Levine, M. H., Beier, U. H., Diamond, J. M., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.94075 · Cited by 66
Castro, I., Yu, A., Dee, M. J., & Malek, T. R. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003961 · Cited by 64
Self-citationControl of tissue‐localized immune responses by human regulatory T cells
Pesenacker, A. M., Broady, R. C., & Levings, M. K. (2014) · European Journal of Immunology · doi:10.1002/eji.201344205 · Cited by 58
Epitope spreading within lupus-associated ribonucleoprotein antigens
Deshmukh, U. S., Bagavant, H., Lewis, J. E., Gaskin, F., & Fu, S. M. (2005) · Clinical Immunology · doi:10.1016/j.clim.2005.07.002 · Cited by 58
Psoriasis patients exhibit impairment of the high potency CCR5+ T regulatory cell subset
Soler, D. C., Sugiyama, H., Young, A. B., Massari, J. V., McCormick, T. S., & Cooper, K. D. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.06.007 · Cited by 58
Lemoine, F. M. (2009) · International Journal of Oncology · doi:10.3892/ijo_00000368 · Cited by 55
Sharabi, A., & Mozes, E. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3243 · Cited by 55
Self-citationSpecific HDAC6 inhibition by ACY-738 reduces SLE pathogenesis in NZB/W mice
Regna, N. L., Vieson, M. D., Luo, X., Chafin, C. B., Puthiyaveetil, A. G., Hammond, S. E., Caudell, D. L., Jarpe, M. B., & Reilly, C. M. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.11.007 · Cited by 54
Kreitman, R. J., Stetler‐Stevenson, M., Jaffe, E. S., Conlon, K. C., Steinberg, S. M., Wilson, W. H., Waldmann, T. A., & Pastan, I. H. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1412 · Cited by 53
Regulatory T cell number in multiple sclerosis patients: A meta-analysis
Noori-Zadeh, A., Mesbah‐Namin, S. A., Bistoon-beigloo, S., Bakhtiyari, S., Abbaszadeh, H., Darabi, S., Rajabibazl, M., & Abdanipour, A. (2015) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2015.11.004 · Cited by 53
Metabolic Regulation of Regulatory T Cell Development and Function
Coe, D., Kishore, M., & Marelli‐Berg, F. M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00590 · Cited by 50
Sthoeger, Z. M., Sharabi, A., Molad, Y., et al. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.03.009 · Cited by 50
Self-citationAntigen-specific regulatory T cells: are police CARs the answer?
Dawson, N. A. J., & Levings, M. K. (2017) · Translational research · doi:10.1016/j.trsl.2017.06.009 · Cited by 50
Cyclosporine for Treatment of Early Type I Diabetes: Preliminary Results
(1983) · New England Journal of Medicine · doi:10.1056/nejm198305193082013 · Cited by 50
Zhang, K., Li, X., Yin, G., Liu, Y., Niu, X., & Hou, R. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08359.x · Cited by 46
Behzad, M., Oflazer, P., Aysal, F., Durmuş, H., Gülşen-Parman, Y., Marx, A., Deymeer, F., & Saruhan‐Direskeneli, G. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.03.008 · Cited by 45
Adair, P., Kim, Y. C., Zhang, A.-H., Yoon, J., & Scott, D. W. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01117 · Cited by 43
Landau, D. A., Rosenzwajg, M., Saadoun, D., Trebeden‐Negre, H., Klatzmann, D., & Cacoub, P. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23759 · Cited by 42
Self-citationSaifuddin, M., Hossain, A. B. M. S., Normaniza, O., Boyce, A. N., & Moneruzzam, K. M. (2009) · Biotechnology(Faisalabad) · doi:10.3923/biotech.2009.343.350 · Cited by 39
Bergot, A., Chaara, W., Ruggiero, E., Mariotti‐Ferrandiz, E., Dulauroy, S., Schmidt, M., Kalle, C. V., Six, A., & Klatzmann, D. (2015) · European Journal of Immunology · doi:10.1002/eji.201445269 · Cited by 33
Self-citationAnaphylaxis caused by repetitive doses of a GITR agonist monoclonal antibody in mice
Murphy, J. T., Burey, A. P., Beebe, A. M., Gu, D., Presta, L. G., Merghoub, T., & Wolchok, J. D. (2014) · Blood · doi:10.1182/blood-2013-12-544742 · Cited by 32
The Relationship of Immune Cell Signatures to Patient Survival Varies within and between Tumor Types
Linsley, P. S., Chaussabel, D., & Speake, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138726 · Cited by 25
Sharabi, A., Lapter, S., & Mozes, E. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.06.002 · Cited by 24
Self-citationKnow thy enemy: Why are tumor-infiltrating regulatory T cells so deleterious?
Facciabene, A., Santoro, S. P., & Coukos, G. (2012) · OncoImmunology · doi:10.4161/onci.19401 · Cited by 18
Maury, S., Rosenzwajg, M., Redjoul, R., Marçais, A., Xhaard, A., Cheraï, M., Cabanne, L., Churlaud, G., Suárez, F., Socié, G., et al. (2014) · Leukemia · doi:10.1038/leu.2014.237 · Cited by 18
Self-citation
Cited by
Inflammation and tumor progression: signaling pathways and targeted intervention
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 2,792
Revisiting the role of CD4+ T cells in cancer immunotherapy—new insights into old paradigms
Tay, R. E., Richardson, E. K., & Toh, H. C. (2021) · Cancer Gene Therapy · doi:10.1038/s41417-020-0183-x · Cited by 813
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets
Tie, Y., Tang, F., Wei, Y.-Q., & Wei, X.-W. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01282-8 · Cited by 591
Autoimmunity and organ damage in systemic lupus erythematosus
Tsokos, G. C. (2020) · Nature Immunology · doi:10.1038/s41590-020-0677-6 · Cited by 580
Self-citationEffects of Omega-3 Fatty Acids on Immune Cells
Gutiérrez, S., Svahn, S. L., & Johansson, M. E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205028 · Cited by 525
Metadata
- Authors
- Sharabi, A., Tsokos, M. G., Ding, Y., Malek, T. R., Klatzmann, D., & Tsokos, G. C.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2018-10-12
- Volume
- 17
- Issue
- 11
- Pages
- 823-844
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2896517179
- Cited by
- 297
- References
- 310
- FWCI
- 3.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.